Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LYT-200 |
Trade Name | |
Synonyms | LYT 200|LYT200 |
Drug Descriptions |
LYT-200 is an antibody that targets Galectin-9, potentially leading to increased tumor cell death (Blood (2021) 138 (Supplement 1): 4400). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C177412 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + LYT-200 + Nab-paclitaxel | Gemcitabine LYT-200 Nab-paclitaxel | 0 | 1 |
LYT-200 | LYT-200 | 0 | 2 |
LYT-200 + unspecified PD-1 antibody | LYT-200 unspecified PD-1 antibody | 0 | 1 |